Customize
Quick Links
Past Events

Accreditation/
Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.


Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for a maximum of 22.0 contact hours (0.22 CEUs).

Acknowledgment of Commercial Support

This activity is supported by educational grants from Ariad Pharmaceuticals, Inc., AstraZeneca, Celgene Corporation, Clovis Oncology, Eisai, Exelixis, Inc., Genomic Health, Inc., Incyte, Lilly, Medivation, Inc., Merck, NantHealth, Inc., Novartis Pharmaceuticals Corporation, Novocure Inc., Pfizer, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Taiho Oncology, Inc., Takeda Oncology, Tesaro, and Teva Pharmaceuticals.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.



The Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is wholly owned and operated by PER Events, LLC, an affiliate of Physicians' Education Resource®.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

34th Annual CFS Chemotherapy Foundation Satellite Symposium

34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®


Friday, November 11, 2016
8:30AM - 10:00 AM
CME-Certified Concurrent Symposium - Live Taping: Renal Cell Carcinoma in an Era of Rapid Discovery:
Key Questions
 
New York Marriott Marquis
1535 Broadway
New York, NY 10036
Room: Julliard Complex (5th Floor)

 

Registration

Registration is complimentary, but seating is limited. Please register here.
 
 
Overview

This edition of Medical Crossfire®, filmed in conjunction with the 34th Annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®, is designed to provide a dynamic discussion of current and evolving paradigms in the treatment of advanced renal cell carcinoma (RCC), including therapeutic sequencing, new targeted and immunotherapeutic agents, TKI resistance, and individualization of therapy. The Activity Chair, Robert Figlin, MD, along with our expert faculty, will emphasize the cutting-edge clinical research that is already shaping their practice, or is likely to do so in the not-too-distant future.
 
During this 60-minute CME-certified activity, the faculty will exchange perspectives and opinions on 5 key clinically relevant questions related to therapeutic resistance, newly approved therapeutics, recently reported long-term overall survival data, subgroup analyses from landmark studies, treatment selection and sequencing, as well as real-world experiences with treatment-related side effects. 

Target Audience
This activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, and urologists who treat patients with renal cell carcinoma (RCC). Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare providers who are interested in the care of patients with RCC may also attend.
 

Educational Objectives

Upon completion of this activity, participants will be better prepared to:
  • Explain targeted and immunotherapeutic mechanistic approaches to overcome anti-angiogenic resistance in the management of RCC
  • Describe evidence-based approaches that inform optimized sequencing of current and emerging strategies for RCC
  • Discuss proactive measures to manage and mitigate treatment-related side effects associated with approaches for advanced RCC
  • Critically evaluate recent clinical trial data in the context of the established evidence guiding individualized treatment planning for patients with advanced RCC


 
 
Activity Chair



Robert A. Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology Oncology
Deputy Director
Samuel Oschin Comprehensive Cancer Institute
                                  Cedars-Sinai Medical Center
 

Faculty


David F. McDermott, MD
Leader, Dana-Farber Harvard Cancer Center Kidney Cancer Program
Director, Biologic Therapy and Cutaneous Oncology Programs, Beth Israel Deaconess
Medical Center
Associate Professor of Medicine, Harvard Medical School Boston,


Robert . Motzer, MD, MPH
Memorial Sloan Kettering Cancer Center
Oncology Specialist
Memorial Sloan Kettering Cancer
New York, NY


Elizabeth Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology
Director, Genitourinary Clinical Research
Associate Professor, Department of Hematology/Oncology
Fox Chase Cancer Center

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Aknowledgement of Commercial Support

This activity is supported by an educational grant from Exelixis, Inc.
 

Photos from the 34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®














Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By